Traditionally, drug discovery relied heavily on trial and error, with long timelines and high costs. The introduction of ...

Seven biotech unicorns are advancing AI-powered drug discovery and development—but must contend with a difficult investing ...

Google gave an update on various aspects of its health-related R&D at its annual event The Check Up, including a new collection of artificial intelligence (AI) models intended to support drug ...

Historian Niall Ferguson warns against unlimited access to AI tools for those under 25, calling it a disaster for brain development.

One of the biggest barriers to the adoption of any new biotechnology tool is validation and regulatory clarity.

RXRX is scaling its AI-driven drug discovery technology through billion-dollar pharma deals and strategic tech alliances.

Wayve was among the first unicorn AI startups in the UK, getting funding of over $1 billion for its self-driving artificial ...

Bill Gates has warned that AI will replace many jobs, but says coding will stay a fully human profession, even hundreds of ...

AI and PLTR are redefining enterprise AI with sharply different strategies. See how their visions for the future stack up.

Below are the most-read DIGITIMES Asia stories from July 7 to July 13, 2025. This week's top three highlights include China’s ...

The global agentic AI in healthcare market is set to witness a growth rate of 35-40% in the next 5 years. Increasing demand ...

Onda on Wednesday launched a free ap for surfers that personalizes local weather forecasts and community updates, starting ...